Effective palliation of patients with incurable neuroendocrine tumors requires both control of hormonal overproduction symptoms as well as control of tumor growth. Several important advances have been made in recent years toward these two goals. Octreotide and omeprazole have both been extremely eff
β¦ LIBER β¦
Treatment of neuroendocrine tumors with somatostatin analogs
β Scribed by Eva Tiensuu Janson
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 188 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1386-341X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Palliative treatment of neuroendocrine t
β
Dr. J. Gregory McKinnon
π
Article
π
1993
π
John Wiley and Sons
π
English
β 704 KB
Treatment of gastroenteropancreatic neur
β
U. PlΓΆckinger; B. Wiedenmann
π
Article
π
2007
π
Springer
π
English
β 196 KB
Somatostatin Receptor Subtypes, Octreoti
β
Lars KΓΆlby; Bo WΓ€ngberg; HΓ₯kan Ahlman; Lars-Erik Tisell; Martha FjΓ€lling; Eva Fo
π
Article
π
1998
π
Springer
π
English
β 673 KB
The treatment of undifferentiated neuroe
β
Emmanuel Mitry; Philippe Rougier
π
Article
π
2001
π
Elsevier Science
π
English
β 62 KB
The aggressiveness of poorly-differentiated neuroendocrine tumors is similar to small-cell lung cancer within a median survival of 6 months without treatment. Most patients have metastatic disease and poor condition at the time of diagnosis, and cannot be approached surgically with curative intent.
Surgical treatment of gastrointestinal n
β
Volker Fendrich; Detlef K. Bartsch
π
Article
π
2011
π
Springer
π
English
β 683 KB
Treatment of liver metastases in patient
β
Andreja Frilling; Xavier Rogiers; Massimo MalagΓ³; Olaf M. Liedke; Michael Kaun;
π
Article
π
1998
π
Springer
π
English
β 508 KB